A novel disintegrin salmosin inhibits tumor angiogenesis

Cancer Research

Volumn 59, Issue 15, 1999, Pages 3754-3760

  Kang, In Cheol ^a   Lee, Young Don ^b   Kim, Doo Sik ^a  

^a Yonsei University   (South Korea)

^b Ajou University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; BASIC FIBROBLAST GROWTH FACTOR; DISINTEGRIN; INTEGRIN; SALMOSIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CANCER INHIBITION; CAPILLARY ENDOTHELIUM; CELL PROLIFERATION; ENDOTHELIUM CELL; GROWTH INHIBITION; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; THROMBOCYTE AGGREGATION; TUMOR GROWTH;

ALLANTOIS; ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA; CATTLE; CELL ADHESION; CELLS, CULTURED; CHICK EMBRYO; CHORION; CROTALID VENOMS; ENDOTHELIUM, VASCULAR; FIBROBLAST GROWTH FACTOR 2; LUNG NEOPLASMS; MICE; MICE, INBRED C57BL; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; OLIGOPEPTIDES; RECEPTORS, VITRONECTIN; TUMOR CELLS, CULTURED; VITRONECTIN;

EID: 0033178713     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Folkman, J., and D'Amore, P. A. Blood vessel formation: what is its molecular basis? Cell, 87: 1153-1155, 1996.
2. Folkman, J., and Shing, Y., Angiogenesis. J. Biol. Chem., 267, 10931-10934, 1992.
3. Nguyen, M., Strubel, N. A., and Bischoff, J. A role of sialyl Lewis-X/A glycoconjugates in capillary morphogenesis. Nature (Lond.), 365: 267-269, 1993.
4. Rastinejad, F., Polverini, P. J., and Bouck, N. P. Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell, 56: 345-355, 1989.
5. O'Reilly, M. S., Holmgren, L., Chen, C., Rosenthal, R. A., Moses, M., Lane, W. S., Cao, Y., Sage, E. H., and Folkman, J. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell, 79: 315-328, 1994.
6. Parangi, S., O'Reilly, M. S., Christofori, G., Holmgren, L., Grosfeld, J., Folkman, J., and Hanahan, D. Antiangiogenic therapy of transgenic mice impairs de novo tumor growth. Proc. Natl. Acad. Sci. USA, 93: 2002-2007, 1996.
7. ν integrins. Science (Washington DC), 270: 1500-1502, 1995.
8. 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell, 79: 1157-1164, 1994.
9. Friesel, R., Komoriya, A., and Maciag, T. Inhibition of endothelial cell proliferation by γ-interferon. J. Cell. Biol., 104: 689-696, 1987.
10. Ezekowitz, R. A., Mulliken, J. B., and Folkman, J. Interferon-2α therapy for life-threatening hemangiomas of infancy. N. Engl. J. Med., 324: 1456-1463, 1992.
11. Angiolillo, A. L., Sgadari, C., Taub, D. D., Liao, F., Farber, J. M., Miaheshwari, S., Kleinman, H. K., Reaman, G. H., and Tosato, G. Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J. Exp. Med., 182: 155-162, 1995.
12. Strieter, R. M., Kunkel, S. L., Arenberg, D. A., Burdick, M. D., and Polverini, P. J. Interferon γ-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis. Biochem. Biophys. Res. Comm., 210: 51-57, 1995.
13. O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W., Flynn, E., Birkhead, J. R., Olsen, B. R., and Folkman, J. Endostatin. An endogenous inhibitor of angiogenesis and tumor growth. Cell, 88: 277-285, 1997.
14. Cao, Y., Chen, C., Weatherbee, J. A., Tsang, M., and Folkman, J. gro-β, a -C-X-C-chemokine, is an angiogenesis inhibitor that suppresses the growth of Lewis lung carcinoma in mice. J. Exp. Med., 182: 2069-2077, 1995.
15. Clapp, C., Martial, J. A., Guzman, R. C., Rentier-Delrue, F., and Weiner, R. I. The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis. Endocrinology, 133: 1292-1299, 1993.
16. Maione, T., Gray, G. S., Petro, J., Hunt, A. J., Donner, A. L., Bauer, S. I., Carson, H. F., and Sharpe, R. J. Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science (Washington DC), 247: 77-79, 1990.
17. Gupta, S. K., Hassel, T., and Singh, J. P. A potent inhibitor of endothelial cell proliferation is generated by proteolytic cleavage of the chemokine platelet factor 4. Proc. Natl. Acad. Sci. USA, 92: 7799-7803, 1995.
18. Niewiarowski, S., Mclane, M. A., Kloczewiak, M., and Stewart, G. J. Disintegrins and other naturally occurring antagonists of platelet fibrinogen receptors. Semin. Hematol., 31: 289-300, 1994.
19. 1 and in cell adhesion inhibition. Cell Adhes. Commun., 2: 491-501, 1994.
20. Soszka, T., Knudsen, K. A., Beviglia, L., Poggi, A., and Niewiarowski, S. Inhibition of murine melanoma cell-matrix adhesion and experimental metastasis by albolabrin, an RGD-containing peptide isolated from the venom of Trimeresurus albolabris. Exp. Cell Res., 196: 6-12, 1991.
21. Trikha, M., De Clerck, Y. A., and Markland, F. S. Contortrostatin, a snake venom disintegrin, inhibits β1 integrin-mediated human metastatic melanoma cell adhesion and blocks experimental metastasis. Cancer Res., 54: 4993-4998, 1994.
22. 3 for angiogenesis. Science (Washington DC), 264: 569-571, 1994.
23. Kang, I. C., Chung, K. H., Lee, S. J., Yoon, Y. D., Moon, H. M., and Kim, D. S. Purification and molecular cloning of a platelet aggregation inhibitor from the snake (Agkistrodon halys brevicaudus) venom. Thromb. Res., 91: 65-73, 1998.
24. Folkman J., Haudenschild, C. C., and Zetter, B. R. Long-term culture of capillary endothelial cells. Proc. Natl. Acad. Sci. USA, 76: 5217-5221, 1979.
25. 2. Cancer Res., 51: 903-906, 1991.
26. Rouslahti, E., and Reed, J. C. Anchorage dependence, integrins, and apoptosis. Cell, 77: 477-478, 1994.
27. Guadagno, T. M., Ohtsubo, M., Roberts, J. M., and Assoian, R. K. A link between cyclin A expression and adhesion-dependent cell cycle progression. Science (Washington DC), 262: 1572-1575, 1993.
28. Boudreau, N., Werb, Z., and Bissell, M. J. Suppression of apoptosis by basement membrane requires three-dimensional tissue organization and withdrawal from the cell cycle. Proc. Natl. Acad. Sci. USA, 93: 3509-3513, 1996.
29. Meredith, J. E., Fazeli, B., and Schwartz, M. A. The extracellular matrix as a cell survival factor. Mol. Biol. Cell., 4: 953-961, 1993.
30. Boudreau, N., Sympson, C. J., Werb, Z., and Bissel, M. J. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science (Washington DC), 267: 891-893, 1995.
31. 3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen. Proc. Natl. Acad. Sci. USA, 91: 8856-8860, 1994.
32. Felding-Harbermann, B., and Cheresh, D. A. Vitronectin and its receptors. Curr. Opin. Cell. Biol., 5: 864-868, 1993.
33. Koch, A. E., Halloran, M. M., Haskell, C. K., Shah, M. R., and Polverini, P. J. Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature (Lond.), 376: 517-519, 1995.
34. Ferrara, N. Missing link in angiogenesis. Nature (Lond.), 376: 467, 1995.
35. 3 blocks human breast cancer growth and angiogenesis in human skin. J. Clin. Invest., 96: 1815, 1995.
36. Soncin, F. Angiogenin supports endothelial and fibroblast cell adhesion. Proc. Natl. Acad. Sci. USA, 89: 2232, 1992.
37. 3 integrin monoclonal antibody. Biochim. Biophys. Acta, 1336: 445-454, 1997.
38. 3 antagonist and inducing apoptosis. Blood, 92: 3268-3276, 1998.